News Image

Amneal Reports Second Quarter 2025 Financial Results

Provided By GlobeNewswire

Last update: Aug 5, 2025

Q2 2025 Net Revenue of $725 million; GAAP Net Income of $22 million; Diluted Income per Share of $0.07
‒ Adjusted EBITDA of $184 million; Adjusted Diluted EPS of $0.25
‒ Raising 2025 Full Year Guidance ‒
‒ Full Debt Refinancing Reduces Interest Cost and Extends Maturities to 2032 ‒

Read more at globenewswire.com

AMNEAL PHARMACEUTICALS INC

NASDAQ:AMRX (11/6/2025, 12:10:03 PM)

11.71

+0.02 (+0.17%)



Find more stocks in the Stock Screener

AMRX Latest News and Analysis

Follow ChartMill for more